Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Francesc Cobo Valien
27 years of experience
Clinic is certified :
Non-Hodgkin's lymphoma treatment cost in Spain typically starts with a lymphoma blood test ranging from $100 to $300, while primary treatment like chemotherapy runs from $2,500 to $4,500 per cycle. Total expenses depend on the disease stage, specific subtype, and the need for advanced interventions like bone marrow transplantation. Patients often see significant savings compared to the United States. Top medical hubs include Barcelona, Madrid, and Pamplona.
Typical Non-Hodgkin's Lymphoma Treatment Costs in Spain
Bookimed Expert Insight: Patients seeking the highest clinical standards should prioritize JCI-accredited centers like Clinica Universidad de Navarra. For complex pediatric cases, SJD Barcelona Children’s Hospital is a top-3 European oncology leader. Individuals interested in cutting-edge research may find value at Quironsalud Madrid, which offers clinical trials. Families often choose Centro Médico Teknon for its high-profile reputation and specialist expertise in adult oncohematology.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Chemotherapy | from $2,700 | from $2,500 | from $2,500 |
| Bone marrow transplantation | from $36,000 | from $140,000 | from $71,782 |
| Autologous bone marrow transplantation | from $31,500 | from $50,000 | from $40,000 |
Dr. Graupera heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals. His research focuses on pediatric cancer treatments.
Specialist in bone marrow transplantation – Dr. Rives Sola focuses on pediatric hematology at SJD Barcelona Children’s Hospital.
Over 1,100 oncology procedures performed – Dr. Cobo Valien specializes in lymphoma at Centro Médico Teknon.
Professor Bosch is a world-renowned leader in Chronic Lymphocytic Leukemia (CLL) and lymphoproliferative disorders, pioneering new treatments and technologies.